In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Hold rating on Fate Therapeutics (FATE – Research Report), with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback